Other Assets, Noncurrent in USD of INOVIO PHARMACEUTICALS, INC. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
INOVIO PHARMACEUTICALS, INC. quarterly Other Assets, Noncurrent history and change rate from Q4 2010 to Q3 2025.
  • INOVIO PHARMACEUTICALS, INC. Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $2.01M, a 255% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

INOVIO PHARMACEUTICALS, INC. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $2.01M +$1.45M +255% 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $2.01M +$1.43M +243% 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $1.98M +$1.37M +227% 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $1.98M +$1.37M +227% 31 Dec 2024 10-Q 10 Nov 2025
Q3 2024 $566K -$38.9K -6.43% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $586K -$81K -12.1% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $605K -$47.2K -7.23% 31 Mar 2024 10-Q 13 May 2024
Q4 2023 $605K -$78.7K -11.5% 31 Dec 2023 10-K 18 Mar 2025
Q3 2023 $605K -$96.7K -13.8% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $667K -$103K -13.4% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $653K -$621K -48.8% 31 Mar 2023 10-Q 10 May 2023
Q4 2022 $684K -$742K -52% 31 Dec 2022 10-K 06 Mar 2024
Q3 2022 $702K -$1.05M -60% 30 Sep 2022 10-Q 08 Nov 2022
Q2 2022 $770K -$1.06M -57.9% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $1.27M -$24.6M -95.1% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $1.43M -$24.5M -94.5% 31 Dec 2021 10-K 01 Mar 2023
Q3 2021 $1.76M -$15.9M -90.1% 30 Sep 2021 10-Q 09 Nov 2021
Q2 2021 $1.83M -$725K -28.4% 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $25.9M +$23.4M +944% 31 Mar 2021 10-Q 10 May 2021
Q4 2020 $26M +$23.3M +871% 31 Dec 2020 10-K 01 Mar 2022
Q3 2020 $17.6M +$14.9M +546% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $2.56M -$297K -10.4% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $2.48M -$501K -16.8% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 $2.67M +$2.03K +0.08% 31 Dec 2019 10-K 01 Mar 2021
Q3 2019 $2.73M +$105K +4.01% 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 $2.85M +$129K +4.72% 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 $2.98M +$533K +21.8% 31 Mar 2019 10-Q 09 May 2019
Q4 2018 $2.67M +$30.6K +1.16% 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 $2.63M +$428K +19.5% 30 Sep 2018 10-Q 08 Nov 2018
Q2 2018 $2.72M +$1.05M +62.7% 30 Jun 2018 10-Q 07 Aug 2018
Q1 2018 $2.45M +$923K +60.6% 31 Mar 2018 10-Q 09 May 2018
Q4 2017 $2.64M +$526K +24.9% 31 Dec 2017 10-K 12 Mar 2019
Q3 2017 $2.2M +$715K +48.3% 30 Sep 2017 10-Q 08 Nov 2017
Q2 2017 $1.67M +$348K +26.2% 30 Jun 2017 10-Q 08 Aug 2017
Q1 2017 $1.53M +$490K +47.4% 31 Mar 2017 10-Q 10 May 2017
Q4 2016 $2.11M +$1.44M +215% 31 Dec 2016 10-K 14 Mar 2018
Q3 2016 $1.48M +$884K +148% 30 Sep 2016 10-Q 09 Nov 2016
Q2 2016 $1.33M +$745K +128% 30 Jun 2016 10-Q 08 Aug 2016
Q1 2016 $1.03M +$370K +55.6% 31 Mar 2016 10-Q 09 May 2016
Q4 2015 $671K +$196K +41.4% 31 Dec 2015 10-K 15 Mar 2017
Q3 2015 $598K +$45.1K +8.17% 30 Sep 2015 10-Q 09 Nov 2015
Q2 2015 $581K +$87.9K +17.8% 30 Jun 2015 10-Q 10 Aug 2015
Q1 2015 $665K +$104K +18.5% 31 Mar 2015 10-Q 11 May 2015
Q4 2014 $475K +$72.5K +18% 31 Dec 2014 10-K 14 Mar 2016
Q3 2014 $552K +$381K +223% 30 Sep 2014 10-Q 10 Nov 2014
Q2 2014 $493K +$296K +150% 30 Jun 2014 10-Q 11 Aug 2014
Q1 2014 $561K +$428K +320% 31 Mar 2014 10-Q 12 May 2014
Q4 2013 $402K +$268K +200% 31 Dec 2013 10-K 16 Mar 2015
Q3 2013 $171K -$52.1K -23.3% 30 Sep 2013 10-Q 12 Nov 2013
Q2 2013 $197K -$25.9K -11.6% 30 Jun 2013 10-Q 09 Aug 2013
Q1 2013 $134K -$58.4K -30.4% 31 Mar 2013 10-Q 10 May 2013
Q4 2012 $134K -$74.1K -35.6% 31 Dec 2012 10-K 17 Mar 2014
Q3 2012 $223K +$14.8K +7.1% 30 Sep 2012 10-Q 07 Nov 2012
Q2 2012 $223K +$14.8K +7.1% 30 Jun 2012 10-Q 09 Aug 2012
Q1 2012 $192K 31 Mar 2012 10-Q 09 May 2012
Q4 2011 $208K -$50.9K -19.6% 31 Dec 2011 10-K 18 Mar 2013
Q3 2011 $208K 30 Sep 2011 10-Q 07 Nov 2011
Q2 2011 $208K 30 Jun 2011 10-Q 05 Aug 2011
Q4 2010 $259K 31 Dec 2010 10-K 15 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.